Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1365, 2002-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dalteparin cost-effective for postop DVT prophylaxis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 573, 2009-01 ,pp. :
Alteplase cost-effective option for acute ischaemic stroke
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 333, 2001-01 ,pp. :
CRT a cost-effective option in Scandinavian settings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 568, 2008-01 ,pp. :
Ezetimibe cost-effective option in statin intolerance
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 571, 2009-01 ,pp. :
Genetic screening for HCM a "highly cost-effective" option
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 602, 2010-01 ,pp. :